Emergency Department, Careggi Teaching Hospital and University of Florence, Florence, Italy.
Scand J Trauma Resusc Emerg Med. 2009 May 21;17:23. doi: 10.1186/1757-7241-17-23.
Continuous monitoring of central venous oxygen saturation (ScvO2) has been proposed as a prognostic indicator in several pathological conditions, including cardiac diseases, sepsis, trauma. To our knowledge, no studies have evaluated ScvO2 in polytraumatized patients with brain injury so far. Thus, the aim of the present study was to assess the prognostic role of ScvO2 monitoring during first 24 hours after trauma in this patients' population.
This prospective, non-controlled study, carried out between April 2006 and March 2008, was performed in a higher level Trauma Center in Florence (Italy). In the study period, 121 patients affected by major brain injury after major trauma were recruited. Inclusion criteria were: 1. Glasgow Coma Scale (GCS) score <or= 13; 2. an Injury Severity Score (ISS) >or= 15. Exclusion criteria included: 1. pregnancy; 2. age < 14 years; 3. isolated head trauma; 4. death within the first 24 hours from the event; 5. the lack of ScvO2 monitoring within 2 hours from the trauma. Demographic and clinical data were collected, including Abbreviated Injury Scale (AIS), Injury Severity Score (ISS), Simplified Acute Physiologic Score II (SAPS II), Marshall score. The worst values of lactate and ScvO2 within the first 24 hours from trauma, ICU length of stay (LOS), and 28-day mortality were recorded.
Patients who deceased within 28 days showed higher age (53 +/- 16.6 vs 43.8 +/- 19.6, P = 0.043), ISS core (39.3 +/- 14 vs 30.3 +/- 10.1, P < 0.001), AIS score for head/neck (4.5 +/- 0.7 vs 3.4 +/- 1.2, P = 0.001), SAPS II score (51.3 +/- 14.1 vs 42.5 +/- 15, P = 0.014), Marshall Score (3.5 +/- 0.7 vs 2.3 +/- 0.7, P < 0.001) and arterial lactate concentration (3.3 +/- 1.8 vs 6.7 +/- 4.2, P < 0.001), than survived patients, whereas ScvO2 resulted significantly lower (66.7% +/- 11.9 vs 70.1% +/- 8.9 vs, respectively; P = 0.046). Patients with ScvO2 values <or= 65% also showed higher 28-days mortality rate (31.3% vs 13.5%, P = 0.034), ICU LOS (28.5 +/- 15.2 vs 16.6 +/- 13.8, P < 0.001), and total hospital LOS (45.1 +/- 20.8 vs 33.2 +/- 24, P = 0.046) than patients with ScvO2 > 65%.
ScvO2 value less than 65%, measured in the first 24 hours after admission in patients with major trauma and head injury, was associated with higher mortality and prolonged hospitalization.
连续监测中心静脉血氧饱和度(ScvO2)已被提出作为几种病理状况(包括心脏病、败血症、创伤)的预后指标。据我们所知,到目前为止,还没有研究评估颅脑损伤多发伤患者的 ScvO2。因此,本研究的目的是评估在这些患者人群中创伤后 24 小时内监测 ScvO2 的预后作用。
本前瞻性、非对照研究于 2006 年 4 月至 2008 年 3 月在佛罗伦萨(意大利)的一家高级创伤中心进行。在研究期间,共招募了 121 名颅脑损伤严重的多发伤患者。纳入标准为:1.格拉斯哥昏迷量表(GCS)评分≤13;2.损伤严重程度评分(ISS)≥15。排除标准包括:1.妊娠;2.年龄<14 岁;3.单纯性颅脑损伤;4.伤后 24 小时内死亡;5.伤后 2 小时内未进行 ScvO2 监测。收集了人口统计学和临床数据,包括损伤严重程度量表(AIS)、损伤严重程度评分(ISS)、简化急性生理评分 II(SAPS II)、马歇尔评分。记录了创伤后 24 小时内最差的乳酸和 ScvO2 值、ICU 住院时间(LOS)和 28 天死亡率。
在 28 天内死亡的患者年龄更大(53±16.6 vs 43.8±19.6,P=0.043)、ISS 核心(39.3±14 vs 30.3±10.1,P<0.001)、头/颈 AIS 评分(4.5±0.7 vs 3.4±1.2,P=0.001)、SAPS II 评分(51.3±14.1 vs 42.5±15,P=0.014)、马歇尔评分(3.5±0.7 vs 2.3±0.7,P<0.001)和动脉血乳酸浓度(3.3±1.8 vs 6.7±4.2,P<0.001),均高于存活患者,而 ScvO2 明显较低(66.7%±11.9 vs 70.1%±8.9,分别;P=0.046)。ScvO2 值≤65%的患者 28 天死亡率(31.3% vs 13.5%,P=0.034)、ICU LOS(28.5±15.2 vs 16.6±13.8,P<0.001)和总住院 LOS(45.1±20.8 vs 33.2±24,P=0.046)均高于 ScvO2>65%的患者。
颅脑损伤多发伤患者入院后 24 小时内测量的 ScvO2 值<65%,与死亡率较高和住院时间延长有关。